Related Experiment Videos
[Studies on urinary apolipoprotein H in diabetics]
Y Yoshimoto1, K Takamatsu, K Yoshida
1Second Department of Internal Medicine, Kochi Medical School, Japan.
Nihon Jinzo Gakkai Shi
|March 1, 1993
Summary
Urinary apolipoprotein H (apo H) levels are elevated in diabetics, even those without overt nephropathy. Increased urinary apo H correlates with markers of kidney damage, suggesting its diagnostic potential in diabetic kidney disease.
Area of Science:
- Nephrology
- Diabetology
- Biochemistry
Context:
- Diabetic kidney disease (DKD) is a major complication of diabetes mellitus.
- Early detection of DKD is crucial for effective management and prevention of end-stage renal disease.
- Urinary biomarkers are increasingly investigated for their diagnostic and prognostic value in DKD.
Purpose:
- To investigate the diagnostic significance of urinary apolipoprotein H (apo H), also known as beta 2-glycoprotein I, in diabetic patients.
- To assess the relationship between urinary apo H levels and urinary albumin (Alb) levels, as well as clinical profiles in diabetics.
- To explore the correlation of urinary apo H with other markers of kidney injury, such as glycosaminoglycan and N-acetyl-beta-D-glucosaminidase.
Summary:
- Urinary apo H levels were significantly higher in diabetic patients compared to healthy subjects, even in those with normoalbuminuria.
- Elevated urinary apo H levels were observed across different stages of albuminuria in diabetics.
- Urinary apo H showed a positive correlation with urinary glycosaminoglycan and N-acetyl-beta-D-glucosaminidase activity, indicating potential glomerular basement membrane damage.
Impact:
- Urinary apo H may serve as an early diagnostic biomarker for diabetic kidney disease, potentially preceding the development of microalbuminuria.
- This finding could lead to improved screening strategies for DKD in diabetic populations.
- Further research is warranted to validate apo H as a reliable biomarker for DKD progression and management.